First human tests begin for experimental drug CBP-0276
Knowledge-focused
Completed
This early-stage trial evaluates the safety and tolerability of an experimental drug called CBP-0276 in healthy adults aged 18 to 64. Participants receive either the drug or a placebo in single or multiple doses, and researchers monitor for side effects and how the drug moves thr…
Phase: PHASE1 • Sponsor: Clarent Biopharma, Inc. • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC